ArticleComprehensive psychoneuroendocrinology2025
Using machine learning models to predict the risk of mild cognitive impairment for COPD patients: A multi-cohort study.
Article in Comprehensive psychoneuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The evaluation of cognitive function in patients with chronic obstructive pulmonary disease (COPD) is critical. This study aimed to construct a risk prediction model capable of predicting the rsik of mild cognitive impairment (MCI) in COPD patients using machine learning methods. Methods: This study enrolled 2142 COPD patients from the China Health and Retirement Longitudinal Study (CHARLS), analyzing 16 sociodemographic, health, and psychological indicators. The predictors screened by LASSO regression were integrated with five machine learning models-Logistic Regression, Neural Network, XGBoost, LightGBM, and Random Forest -to identify the optimal model for predicting MCI risk in COPD patients. External validation was conducted using the Health and Retirement Study dataset (HRS). Model performance underwent comprehensive evaluation across three critical dimensions: discrimination capacity (AUC-ROC), calibration accuracy (Brier score and calibration curves), and clinical applicability (decision curve analysis). Additionally, the SHAP method was employed to elucidate the feature contributions to the final model. Results: The analysis included 2142 COPD patients, of whom 420 were diagnosed with MCI. 11 predictive variables were selected to construct five machine learning algorithms. Among these, the LightGBM model demonstrated superior performance across all evaluation dimensions - including discrimination capacity, calibration accuracy, and clinical utility - achieving AUROC values ranging from 0.722 to 0.782.The eight most significant features for predicting MCI in COPD patients were sex, residence, instrumental activities of daily living (IADL) score, educational level, social activity engagement, marital status, Internet use and depression. Conclusion: The machine learning model accurately predicts MCI risk in COPD patients, enabling timely clinical interventions and improved care through early identification of high-risk individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.